| For: | Matsathit U, Komolkriengkrai M, Khimmaktong W. Glabridin and gymnemic acid alleviates choroid structural change and choriocapillaris impairment in diabetic rat’s eyes. World J Diabetes 2025; 16(3): 97336 [PMID: 40093291 DOI: 10.4239/wjd.v16.i3.97336] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i3/97336.htm |
| Number | Citing Articles |
| 1 |
Sedef Ziyanok-Demirtas, Irem Serin. Gymnema sylvestre as a Multi-Target Antidiabetic Agent: Mechanistic Insights and Metabolic Regulation. International Journal of Molecular Sciences 2026; 27(12) doi: 10.3390/ijms27125609
|
| 2 |
Hongtao Tan, Yicong Li, Yingshan Li, Junxian Chen, Weiwei Yuan. Glabridin attenuates diabetic cardiomyopathy by activating AMPK to suppress ferroptosis and TGF-β-mediated myocardial fibrosis. Biochemical and Biophysical Research Communications 2026; 815 doi: 10.1016/j.bbrc.2026.153580
|
| 3 |
Yueling Cui, Tao Wang, Linqiong Wang, Hengyan Hua, Zhaoxi Song, Xinyu Zhao, Wei Tan. Investigation of the impact of choroidal capillary flow area on macular ischemia in diabetic patients. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-07130-2
|